Literature DB >> 14631599

[The role of cytokines in depression].

Halina Dubas-Slemp1, Halina Marmurowska-Michałowska, Agnieszka Szuster-Ciesielska, Teresa Kamińska, Martyna Kandefer-Szerszeń.   

Abstract

Clinical and experimental studies on animals indicate that depression is associated with increased plasma cytokine acute phase protein concentrations and hypothalamic-pituitary-adrenal axis (HPA) activation. Additionally it has been detected that immunological activation induces stress-like behavioural and neurochemical changes in organisms of animals and humans. Hypersecretion of cytokines in response to stress or to endogenous trigger factors may induce depressive symptoms. Corticotropin releasing hormone (CRH) overproduction in the brain also may participate in cytokine-induced behavioural and neurochemical changes. Treatment with antidepressants conferred protection against cytokine-induced depressive-like biological and behavioural changes. This is mainly due to alterations of the pro-/anti-inflammatory cytokine balance. There is a substantial body of evidence that the immune system plays a major role in aetiology of depression and that cytokines participate in neurochemical, behavioural and endocrine changes in this illness.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14631599

Source DB:  PubMed          Journal:  Psychiatr Pol        ISSN: 0033-2674            Impact factor:   1.657


  2 in total

1.  Elevated IL-17 and TGF-β Serum Levels: A Positive Correlation between T-helper 17 Cell-Related Pro-Inflammatory Responses with Major Depressive Disorder.

Authors:  Mohammad Hasan Davami; Rasoul Baharlou; Abbas Ahmadi Vasmehjani; Ahmad Ghanizadeh; Mitra Keshtkar; Iman Dezhkam; Mohammad Reza Atashzar
Journal:  Basic Clin Neurosci       Date:  2016-04

2.  Plasma Levels of IL-23 and IL-17 before and after Antidepressant Treatment in Patients with Major Depressive Disorder.

Authors:  Jae-Won Kim; Yong-Ku Kim; Jung-A Hwang; Ho-Kyoung Yoon; Young-Hoon Ko; Changsu Han; Heon-Jeong Lee; Byung-Joo Ham; Hong Seock Lee
Journal:  Psychiatry Investig       Date:  2013-09-16       Impact factor: 2.505

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.